December 2015 - Managedcaremag.com

Inhaltsverzeichnis Anzeigen

2016: Year in Preview

We’re unwrapping the future. Here’s our list of 11 developments in the next 12 months that will change the course of American health care for many years to come.

Big meets even bigger: More consolidation in the offing

On or off track? 2016 could be the year that value-based payment arrives – or maybe not

Sagging sign-ups: Slowing enrollment may mean big trouble for the ACA

Sticker shock waves: Players to respond to drug priciness

Picking up the tab: Out-of-network bills will be a hot issue

Slimming too fast: New rules coming for narrowing networks

The hunger gains: Appetite for quality to grow

The 2016 election season: Democrats to play D while GOP devises a game plan

Cyberthievery: Will health care companies respond in 2016?

Doing the MACRA-ena: Will the celebrations continue in 2016?

Too much of a good thing: Overdiagnosis to get its due

Growing testiness: Disagreements between insurers, labs about new molecular tests

A Conversation with John Driscoll, CEO, CareCentrix

Post-Acute Care Vendors Allow Plans To Focus on Hospital, Medical Costs

Interview by Peter Wehrwein

Using Alternatives to Opioids In an Acute Care Setting

Health System Selects SNFs To Improve Overall Care

Incremental Hospital Costs Associated With Comorbidities of Prematurity

Departments

LEGISLATION & REGULATION

ACA Co-Ops Continue To Falter and Drop Out

Only 11 of the not-for-profit health plans are still operating, and the program that would cushion them from financial losses is in trouble. Will it be fixed?

SNAPSHOT

Commercial insurers saying ‘no’ to hospitals more often

MEDICATION MANAGEMENT

ASCO, Others Design Tools To Measure the Worth of Drugs

Pharmaceutical companies still hold important cards when it comes to negotiating prices, but that may change with new ways of measuring value.

CANCER WATCH

Philadelphia’s Fox Chase In Pursuit of Fewer Readmissions

The country’s elite cancer hospitals may be facing a less coddled existence. Fox Chase is getting ahead of the game with efforts to reduce readmissions.

TOMORROW’S MEDICINE

Expensive New Biologic Helps Children Fight Hypophosphatasia

At last there is a treatment for the inherited condition that affects bone development. But at $300,000 per year, cost is a major issue.

MEDICAL DEVICE MONITOR

Digital Health Technology Adoption Depends On Tech Comfort Level, Willingness to Pay

MANAGED CARE OUTLOOK

AAMC: Physician shortage less severe than previously projected

News & Commentary

Health Effects of Heaviness May Explain Prescription Drug Spike

‘Beyond the Pill’ Care Now Expected Add-on

Plugging the Chronic Pain Money Drain

Dementia’s true costs not a problem for insurers (yet)

Paul Lendner

Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.